Sex BehaviorEROSSNCT04776902
Effects of Ovarian Reserve on Sexual Satisfaction
A study testing Survey in people with Sex Behavior and Ovarian Failure, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
This is a survey study. The primary aim of the study is to investigate the relationship between the ovarian reserve and sexual satisfaction. All the patients who underwent ovarian reserve assessment for any reason will fill a questionnaire about sexual satisfaction. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Sex Behavior, Ovarian Failure
- What is being tested?
- Survey
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2020to 1 Jun 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Patients who admitted to the gynecology clinic for any reason
- Patients with ovarian reserve tests
- 18-45 years
Who cannot join
- Mental disorders
- Anatomic genital malformations
- Patient' Decline to fill the survey
- Presence of malignancy
- Without any sexual activity
Trial locations and contacts
1 site in 1 country.
About this study
This is a survey study. The primary aim of the study is to investigate the relationship between the ovarian reserve and sexual satisfaction. All the patients who underwent ovarian reserve assessment for any reason will fill a questionnaire about sexual satisfaction. And the survey results will be compared with patients' ovarian reserve.
- Conditions
- Sex Behavior, Ovarian Failure
- Being tested
- Survey
- Keywords
- Ovarian Reserve, Sexual Satisfaction
- Medical subject headings
- Sexual Behavior, Orgasm
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyBehavioural
Patients will fill a questionary with 8 questions.
| Study group | Role | What they receive |
|---|---|---|
| Study Group | Other | All patients will be enrolled in one arm Receives: Behavioral: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sexual Satisfaction Score
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2021
- Study start1 Oct 2020
- Primary completion1 May 2021
- Study completion1 Jun 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Sex BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Survey Study
- Masking
- None (open label)
- Enrolment
- 180 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, GÜRKAN UNCU,PROF. MD, Uludag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04776902
- Sponsor's protocol ID
- 2020-2/8
- Acronym
- EROSS
- Status last verified
- Jun 2022
- First submitted
- 25 Feb 2021
- Last updated
- 13 Jun 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kulahci Aslan E, Aslan K, Gurluler J, Uyaniklar O, Kilik T, Turk P, Ozden O, Kasapoglu I, Uncu G. EROSS study: effect of ovarian reserve on sexual satisfaction. J Obstet Gynaecol. 2022 Oct;42(7):3055-3060. doi: 10.1080/01443615.2022.2081798. Epub 2022 Jun 6.
PubMed 35666951
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Ovarian Reserve on Sexual Satisfaction
- ClinicalTrials.gov ID
- NCT04776902
- Acronym / sponsor ID
- EROSS / 2020-2/8
- Conditions
- Sex Behavior, Ovarian Failure
- Keywords
- Ovarian Reserve, Sexual Satisfaction
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 180 participants (actual)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 1 Oct 2020 (actual)
- Primary completion
- 1 May 2021 (actual)
- Study completion
- 1 Jun 2021 (actual)
- First posted
- 2 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a survey study. The primary aim of the study is to investigate the relationship between the ovarian reserve and sexual satisfaction. All the patients who underwent ovarian reserve assessment for any reason will fill a questionnaire about sexual satisfaction. And the survey results will be compared with patients' ovarian reserve.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Survey Study
| Arm | Type | Receives |
|---|---|---|
| Study Group | Other | Behavioral: SurveyAll patients will be enrolled in one arm |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Patients who admitted to the gynecology clinic for any reason
- Patients with ovarian reserve tests
- 18-45 years
Key exclusion criteria (5 listed)
- Mental disorders
- Anatomic genital malformations
- Patient' Decline to fill the survey
- Presence of malignancy
- Without any sexual activity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyPatients will fill a questionary with 8 questions. | Behavioural | Study Group |
Primary outcome
Sexual Satisfaction Score
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2022.
- Derived from this study: PubMed 35666951Kulahci Aslan E, Aslan K, Gurluler J, Uyaniklar O, Kilik T, Turk P, Ozden O, Kasapoglu I, Uncu G. EROSS study: effect of ovarian reserve on sexual satisfaction. J Obstet Gynaecol. 2022 Oct;42(7):3055-3060. doi: 10.1080/01443615.2022.2081798. Epub 2022 Jun 6.
- Individual participant dataSharing planned: No
Related trials for Sex Behavior
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Recruiting
Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact Lab
Reproductive Health, Sexual Health
Not yet recruiting
HC-HMP: Healthy Choices Implementation Trial
Alcohol Drinking, HIV Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Survey in people with Sex Behavior and Ovarian Failure, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sexual Satisfaction Score (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04776902, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2022.